Twist Bioscience stock jumps on early revenue beat as TWST investors eye JPM talk and Feb. 2 results
Shares of Twist Bioscience Corp jumped roughly 8% Monday following a preliminary first-quarter revenue report that beat expectations. The synthetic DNA company’s stock climbed 7.8% to $38.07 in afternoon trading, trading between $34.51 and $39.80 earlier in the session.
